CDKN1A and glioma: Furthermore, these tumors are characterized by activation of Egfr and Mki-67, wild-type p53, low levels of mRNA and CDKN1A and PTEN proteins, and decreased expression and activity of the IDH1/2 enzyme, one of the main markers of gliomas [56].